Persistent URL of this record https://hdl.handle.net/1887/3565037
Documents
-
- Download
- 1-s2.0-S0923753422000837-main
- Publisher's Version
- open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743
- All authors
- Peters, S.; Scherpereel, A.; Cornelissen, R.; Oulkhouir, Y.; Greillier, L.; Kaplan, M.A.; Talbot, T.; Monnet, I.; Hiret, S.; Baas, P.; Nowak, A.K.; Fujimoto, N.; Tsao, A.S.; Mansfield, A.S.; Popat, S.; Zhang, X.; Hu, N.; Balli, D.; Spires, T.; Zalcman, G.
- Date
- 2022-04-18
- Journal
- Annals of Oncology
- Volume
- 33
- Issue
- 5
- Pages
- 488 - 499